STAT November 7, 2025
Ed Silverman

The FDA announced the second batch of companies granted vouchers for speedier drug reviews

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is, so far, rather modest. We plan to tidy up the Pharmalot grounds, promenade with the official mascots, and catch up on our reading. We also hope to hold another listening party, where the rotation will likely include this, this, this, this and this. And what about you? As the weather changes, this is a fine time of year to enjoy all sorts of scenery, so perhaps a trek to the countryside is in...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: Biotechnology, Congress / White House, FDA, Govt Agencies, Insurance, Medicaid, Pharma, Pharma / Biotech
Federal Discretionary Spending To Address Substance Use Disorders: How Big A Shift?
White House and Congress Turn Focus to Health Policy
CVS accused of shutting out rival pharmacy hubs in House Judiciary investigation
OIG Recounts Historic Recovery Numbers in Its Latest Semiannual Report to Congress
What is included in Trump’s “Great Healthcare Plan”?

Share Article